BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B- lymphocyte lineage

Blood

Volumn 94, Issue 11, 1999, Pages 3621-3632

  Chiang, Mark Y ^a   Monroe, John G ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Biomedical Research Bldg II/III   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; RETINOIC ACID; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SURVIVAL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; LYMPHOPOIESIS; NONHUMAN; PLASTICITY; PRIORITY JOURNAL;

EID: 0033485592     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3621     Document Type: Article

References (76)

1. Kulessa H, Frampton J, Graf T: GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 9:1250, 1995
2. Nerlov C, Graf T: PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 12:2403, 1998
3. Sieweke MH, Tekotte H, Frampton J, Graf T: MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85:49, 1996
4. Sieweke MH, Tekotte H, Frampton J, Graf T: MafB represses erythroid genes and differentiation through direct interaction with c-Ets-1. Leukemia 11:486, 1997
5. Kee BL, Murre C: Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med 188:699, 1998
6. Davidson WF, Pierce JH, Rudikoff S, Morse HCd: Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med 168:389, 1988
7. Bauer SR, Holmes KL, Morse HCd, Potter M: Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. J Immunol 136:4695, 1986
8. Boyd AW, Schrader JW: Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature 297:691, 1982
9. Holmes KL, Pierce JH, Davidson WF, Morse HCd: Murine hematopoietic cells with pre-B or pre-B/myeloid characteristics are generated by in vitro transformation with retroviruses containing fes, ras, abl, and src oncogenes. J Exp Med 164:443, 1986
10. Hara H, Sam M, Maki RA, Wu GE, Paige CJ: Characterization of a 70Z/3 pre-B cell derived macrophage clone. Differential expression of Hox family genes. Int Immunol 2:691, 1990
11. Klinken SP, Alexander WS, Adams JM: Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages. Cell 53:857, 1988
12. Borzillo GV, Sherr CJ: Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures. Mol Cell Biol 9:3973, 1989
13. Borzillo GV, Ashmun RA, Sherr CJ: Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol Cell Biol 10:2703, 1990
14. Borrello MA, Phipps RP: The B/macrophage cell: An elusive link between CD5+ B lymphocytes and macrophages. Immunol Today 17:471, 1996
15. Allman D, Li J, Hardy RR: Commitment to the B lymphoid lineage occurs before DH-JH recombination. J Exp Med 189:735, 1999
16. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173:1213, 1991
17. Li YS, Wasserman R, Hayakawa K, Hardy RR: Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5:527, 1996
18. Mahmoud MS, Kawano MM: Cloning and analysis of the human Pax-5 gene promoter. Biochem Biophys Res Commun 228:159, 1996
19. Walther C, Guenet JL, Simon D, Deutsch U, Jostes B, Goulding MD, Plachov D, Balling R, Gruss P: Pax: A murine multigene family of paired box-containing genes. Genomics 11:424, 1991
20. Zwollo P, Arrieta H, Ede K, Molinder K, Desiderio S, Pollock R: The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem 272:10160, 1997
21. Busslinger M, Klix N, Pfeffer P, Graninger PG, Kozmik Z: Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc Natl Acad Sci USA 93:6129, 1996
22. Kozmik Z, Sure U, Ruedi D, Busslinger M, Aguzzi A: Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92:5709, 1995
23. Reimold AM, Ponath PD, Li YS, Hardy RR, David CS, Strominger JL, Glimcher LH: Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein I. J Exp Med 183:393, 1996
24. Nutt SL, Urbanek P, Rolink A, Busslinger M: Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 11:476, 1997
25. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, van der Valk M, te Riele HPJ, Berns A, Murre C: E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885, 1994
26. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901, 1994
27. Okabe T, Watanabe T, Kudo A: A pre-B-and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene. Eur J Immunol 22:37, 1992
28. Zwollo P, Desiderio S: Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. J Biol Chem 269:15310, 1994
29. Fitzsimmons D. Hodsdon W, Wheat W, Maira SM, Wasylyk B, Hagman J: Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev 10:2198, 1996
30. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M: The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 12:2662, 1992
31. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M: Identification of BSAP (Pax-5) target genes in early B-cell development by loss-and gain-of-function experiments. EMBO J 17:2319, 1998
32. McBurney MW, Sutherland LC, Adra CN, Leclair B, Rudnicki MA, Jardine K: The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res 19:5755, 1991
33. Adams B, Dorfler P, Aguzzi A, Kozmik Z, Urbanek P, Maurer-Fogy I, Busslinger M: Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 6:1589, 1992
34. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D: Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92:3780, 1998
35. Tsai S, Bartelmez S, Sitnicka E, Collins S: Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8:2831, 1994
36. Nakano T, Kodama H, Honjo T: Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265:1098, 1994
37. McMahon SB, Monroe JG: A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor cross-linking in B lymphocytes. Mol Cell Biol 15:1086, 1995
38. Czerny T, Schaffner G, Busslinger M: DNA sequence recognition by Pax proteins: Bipartite structure of the paired domain and its binding site. Genes Dev 7:2048, 1993
39. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993
40. Pear W: Transduction of genes using retroviral vectors, in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. Brooklyn, NY, Wiley, 1998, p 9.9.1
41. Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W: Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174:5, 1994
42. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805, 1981
43. Springer T, Galfre G, Secher DS, Milstein C: Mac-1: A macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9:301, 1979
44. Hirsch S. Austyn JM, Gordon S: Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med 154:713, 1981
45. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL: The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci USA 92:10302, 1995
46. McFarland HI, Nahill SR, Maciaszek JW, Welsh RM: CD11b (Mac-1): A marker for CD8+ cytotoxic T cell activation and memory in virus infection. J Immunol 149:1326, 1992
47. Miyama-Inaba M, Kuma S, Inaba K, Ogata H, Iwai H, Yasumizu R, Muramatsu S, Steinman RM, Ikehara S: Unusual phenotype of B cells in the thymus of normal mice. J Exp Med 168:811, 1988
48. Osawa M, Hanada K, Hamada H, Nakauchi H: Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242, 1996
49. Osawa M, Nakamura K, Nishi N, Takahasi N, Tokuomoto Y, Inoue H, Nakauchi H: In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. J Immunol 156:3207, 1996
50. Liao F, Birshtein BK, Busslinger M, Rothman P: The transcription factor BSAP (NF-HB) is essential for immunoglobulin germ-line epsilon transcription. J Immunol 152:2904, 1994
51. Tian J, Okabe T, Miyazaki T, Takeshita S, Kudo A: Pax-5 is identical to EBB-1/KLP and binds to the VpreB and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes. Eur J Immunol 27:750, 1997
52. Singh M, Birshtein BK: NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation. Mol Cell Biol 13:3611, 1993
53. Neurath MF, Max EE, Strober W: Pax5 (BSAP) regulates the murine immunoglobulin 3′ alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc Natl Acad Sci USA 92:5336, 1995
54. Rinkenberger JL, Wallin JJ, Johnson KW, Koshland ME: An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 5:377, 1996
55. Stuart ET, Haffner R, Oren M, Gruss P: Loss of p53 function through PAX-mediated transcriptional repression. EMBO 14:5638, 1995
56. Marcu KB, Xu L, Kim MG: S alpha BP/BSAP/NF-S mu B1, a murine and human B cell stage specific nuclear factor with DNA binding specificity implying roles in switch-recombination and transcription. Curr Top Microbiol Immunol 182:167, 1992
57. Xu L, Kim MG, Marcu KB: Properties of B cell stage specific and ubiquitous nuclear factors binding to immunoglobulin heavy chain gene switch regions. Int Immunol 4:875, 1992
58. Kehrl JH, Riva A, Wilson GL, Thevenin C: Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol Today 15:432, 1994
59. Waters SH, Saikh KU, Stavnezer J: A B-cell-specific nuclear protein that binds to DNA sites 5′ to immunoglobulin S alpha tandem repeats is regulated during differentiation. Mol Cell Biol 9:5594, 1989
60. Rothman P, Chen YY, Lutzker S, Li SC, Stewart V, Coffman R, Alt FW: Structure and expression of germ line immunoglobulin heavy-chain epsilon transcripts: Interleukin-4 plus lipopolysaccharide-directed switching to C epsilon. Mol Cell Biol 10:1672, 1990
61. Roque MC, Smith PA, Blasquez VC: A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3′ enhancer. Mol Cell Biol 16:3138, 1996
62. Sigvardsson M, O'Riordan M, Grosschedl R: EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7:25, 1997
63. Martin M, Strasser A, Baumgarth N, Cicuttini FM, Welch K, Salvaris E, Boyd AW: A novel cellular model (SPGM 1) of switching between the pre-B cell and myelomonocytic lineages. J Immunol 150:4395, 1993
64. Lieschke GJ: CSF-deficient mice - What have they taught us? Ciba Found Symp 204:60, 1997
65. Nishinakamura R, Miyajima A, Mee PJ, Tybulewicz VL, Murray R: Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 88:2458, 1996
66. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte/ macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592, 1994
67. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737, 1994
68. Seymour JF, Lieschke GJ, Grail D, Quilici C, Hodgson G, Dunn AR: Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90:3037, 1997
69. Wiktor-Jedrzejczak WW, Ahmed A, Szczylik C, Skelly RR: Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med 156:1516, 1982
70. Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I: Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 177:237, 1993
71. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, Chisholm O, Hofstetter W, Pollard JW, Stanley ER: Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120:1357, 1994
72. Bassuk AG, Leiden JM: The role of Ets transcription factors in the development and function of the mammalian immune system. Adv Immunol 64:65, 1997
73. Eder M, Griffin JD, Ernst TJ: The human granulocyte-macrophage colony-stimulating factor receptor is capable of initiating signal transduction in NIH3T3 cells. EMBO J 12:1647, 1993
74. Watanabe S, Mui AL, Muto A, Chen JX, Hayashida K, Yokota T, Miyajima A, Arai K: Reconstituted human granulocyte-macrophage colony-stimulating factor receptor transduces growth-promoting signals in mouse NIH 3T3 cells: Comparison with signalling in BA/F3 pro-B cells. Mol Cell Biol 13:1440, 1993
75. Sakamaki K, Miyajima I, Kitamura T, Miyajima A: Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541, 1992
76. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A: Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J 12:4181, 1993